The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  TCDA Date:  10/29/2020  10:32 AM
Author:  12x Number:  25453 of 25553

TCDA is being told by the FDA they need more data. Data that it appears they would need to run a totally new trial.

So they are cutting staff.

Cost restructuring

FDA meeting.
Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us